InvestorsHub Logo
Followers 8
Posts 1891
Boards Moderated 0
Alias Born 05/05/2016

Re: None

Monday, 03/23/2020 7:29:08 PM

Monday, March 23, 2020 7:29:08 PM

Post# of 44784
Hi hopester and FDA!

Thanks for continuing the good fight! I've been following the board very selectively (I'd run out of anti-emetic otherwise).

The fundamental reason for owning this company has not changed. They have deep and growing experience in a very hot and increasingly important area of medical advance. We've had enough positive data to warrant optimism and a commitment of money (that may vary per individual, but it's definitely my opinion)

We've had no failures in the clinic (that is known at this time), and they seem to be moving steadily forward. Yes, it takes time, that is not surprising at all, welcome to biotech investing.

The possibility of playing a role in taming the "cytokine storm" is very exciting (congrats to "Dr.Gary" for anticipating this!). There is pretty good evidence that it's possible, AND the fact that the cells are familiar to clinicians, AND that if it turns out to be effective, Pluristem can produce them en-masse. If it works out the notion of "game changer" is an understatement (both from a clinical and investment perspective).

Best to all,
zzaatt.